Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

ADMA Biologics Q1 Adj. EPS $0.14 Misses $0.16 Estimate, Sales $114.80M Miss $116.40M Estimate

Author: Benzinga Newsdesk | May 07, 2025 03:15pm
ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.16 by 12.5 percent. This is a 75 percent increase over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $114.80 million which missed the analyst consensus estimate of $116.40 million by 1.37 percent. This is a 40.22 percent increase over sales of $81.88 million the same period last year.

Posted In: ADMA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist